An Experimental DUAL Model of Advanced Liver Damage

Autor: Raquel Benedé‐Ubieto, Olga Estévez‐Vázquez, Feifei Guo, Chaobo Chen, Youvika Singh, Helder I. Nakaya, Manuel Gómez del Moral, Arantza Lamas‐Paz, Laura Morán, Nuria López‐Alcántara, Johanna Reissing, Tony Bruns, Matías A. Avila, Eva Santamaría, Marina S. Mazariegos, Marius Maximilian Woitok, Ute Haas, Kang Zheng, Ignacio Juárez, José Manuel Martín‐Villa, Iris Asensio, Javier Vaquero, Maria Isabel Peligros, Josepmaria Argemi, Ramón Bataller, Javier Ampuero, Manuel Romero Gómez, Christian Trautwein, Christian Liedtke, Rafael Bañares, Francisco Javier Cubero, Yulia A. Nevzorova

Publikováno v: Hepatology Communications, Vol 5, Iss 6, Pp 1051-1068 (2021)

Individuals exhibiting an intermediate alcohol drinking pattern in conjunction with signs of metabolic risk present clinical features of both alcohol‐associated and metabolic‐associated fatty liver diseases. However, such combination remains an u

Externí odkaz: https://doaj.org/article/0a79bde68d4940f383cf2ba5f8557b0d

Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease

Autor: Pierluigi Ramadori, Marius Maximilian Woitok, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Hector Leal-Lassalle, Arantza Lamas-Paz, Feifei Guo, Jeanne Fabre, Julia Otto, Anna Verwaayen, Johanna Reissing, Tony Bruns, Stephanie Erschfeld, Ute Haas, Daniela Paffen, Leonard J. Nelson, Javier Vaquero, Rafael Bañares, Christian Trautwein, Francisco Javier Cubero, Christian Liedtke, Yulia A. Nevzorova

Publikováno v: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869:166646

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::03aacf9b24c0bd6221b43e8b8235c246
https://doi.org/10.1016/j.bbadis.2023.166646

A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy

Autor: Feifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Douglas Maya-Miles, Kang Zheng, Rocío Gallego-Durán, Ángela Rojas, Javier Ampuero, Manuel Romero-Gómez, Kaye Philip, Isioma U. Egbuniwe, Chaobo Chen, Jorge Simon, Teresa C. Delgado, María Luz Martínez-Chantar, Jie Sun, Johanna Reissing, Tony Bruns, Arantza Lamas-Paz, Manuel Gómez del Moral, Marius Maximilian Woitok, Javier Vaquero, José R. Regueiro, Christian Liedtke, Christian Trautwein, Rafael Bañares, Francisco Javier Cubero, Yulia A. Nevzorova

Publikováno v: Cancers 14(1), 192 (2022). doi:10.3390/cancers14010192 special issue: "Special Issue "Theranostic Advances in Hepatobiliary Tumors" / Special Issue Editors: Prof. Dr. Matias A. Avila, Guest Editor; Prof. Carmen Berasain, Guest Editor; Prof. Dr. Andrea Casadei-Gardini, Guest Editor"
E-Prints Complutense. Archivo Institucional de la UCM
instname
Cancers
Cancers; Volume 14; Issue 1; Pages: 192
Cancers, Vol 14, Iss 192, p 192 (2022)

Metabolic-associated fatty liver disease (MAFLD) has risen as one of the leading etiologies for hepatocellular carcinoma (HCC). Oncogenes have been suggested to be responsible for the high risk of MAFLD-related HCC. We analyzed the impact of the prot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::350b46ccc3dcbed1e1e7c49f30ceef7a